drugset / Trial / NCT00807014

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne

NCT00807014

Phase 4 Completed 169 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this clinical trial are to compare the quality of life of the subjects, the efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin phosphate \[equivalent to 1% clindamycin\] and 5% benzoyl peroxide), applied once daily, against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to moderate acne vulgaris.

Timeline

Start
2006-11
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.1 % Topical
Subject Benzoyl Peroxide Other / unclassified 5 % Topical
Subject Clindamycin Unknown 1 % Topical

Indications